Logotipo do repositório
 

Publicação:
Efeito dos inibidores de recaptação da serotonina na plasticidade neural após acidente vascular cerebral

dc.contributor.authorLuvizutto, Gustavo José [UNESP]
dc.contributor.authorBazan, Rodrigo
dc.contributor.authorBraga, Gabriel Pereira [UNESP]
dc.contributor.authorKuster, Gustavo Wruck
dc.contributor.authorLange, Marcos Cristiano
dc.contributor.authorZetola, Viviane Flumignan
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionPsicologia e Psiquiatria
dc.contributor.institutionEscola de Medicina do ABC
dc.contributor.institutionUniversidade Federal do Paraná (UFPR)
dc.date.accessioned2018-12-11T16:38:41Z
dc.date.available2018-12-11T16:38:41Z
dc.date.issued2015-06-30
dc.description.abstractIntroduction. Recently, selective serotonin reuptake inhibitors (SSRIs) have been highlighted as neuroplasticity agents for improving functional and motor recuperation in patients after stroke. Objective. Considering the availability of these drugs in our context, even in the public healthcare system, we aimed to undertake a review of the literature in order to improve the decision-making process. Method. The review, based on data up to February 2013,included studies that took into account neuroprotective and anti-fatigue properties, and effect on motor recuperation capacity after stroke. Results. The control and randomized studies (RCT) found: motor recuperation improvement with the use of Fluoxetine, evaluated by the Fugl-Meyer Motor Scale after 90 days of treatment; improvement of functional independence, by modified Rankin scale and Barthel’s index, with the use of Nortriptyline; greater activation in the contralateral sensory-motor cortex after the use of paroxetine and no positive effect on the control of fatigue after stroke. Conclusion. The studies suggest better functional and motor recuperation with SSRI use. It was not possible to determine a difference among the agents, since the available studies are not comparative and were tested with different drugs; these and other gaps are being addressed by ongoing studies.en
dc.description.affiliationNúcleo de Reabilitação UNESP
dc.description.affiliationDepartamento de Neurologia Psicologia e Psiquiatria
dc.description.affiliationUnidade de AVC (UNESP)
dc.description.affiliationEscola de Medicina do ABC
dc.description.affiliationDepartamento de Neurologia do Hospital de Clínicas Universidade Federal do Paraná
dc.description.affiliationUnespNúcleo de Reabilitação UNESP
dc.description.affiliationUnespUnidade de AVC (UNESP)
dc.format.extent291-296
dc.identifierhttp://dx.doi.org/10.4181/RNC.2015.23.02.1010.6p
dc.identifier.citationRevista Neurociencias, v. 23, n. 2, p. 291-296, 2015.
dc.identifier.doi10.4181/RNC.2015.23.02.1010.6p
dc.identifier.issn1984-4905
dc.identifier.issn0104-3579
dc.identifier.scopus2-s2.0-84933503486
dc.identifier.urihttp://hdl.handle.net/11449/167876
dc.language.isopor
dc.relation.ispartofRevista Neurociencias
dc.relation.ispartofsjr0,123
dc.relation.ispartofsjr0,123
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectDrug therapy
dc.subjectMotor activity
dc.subjectNeuronal plasticity
dc.subjectRehabilitation
dc.subjectSerotonin reuptake inhibitors
dc.subjectStroke
dc.titleEfeito dos inibidores de recaptação da serotonina na plasticidade neural após acidente vascular cerebralpt
dc.title.alternativeEffects of serotonin reuptake inhibitors in neuronal plasticity after strokeen
dc.typeArtigo
dspace.entity.typePublication

Arquivos

Coleções